A detailed history of Birchcreek Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Birchcreek Wealth Management, LLC holds 1,815 shares of ABBV stock, worth $323,088. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,815
Previous 2,160 15.97%
Holding current value
$323,088
Previous $370,000 3.24%
% of portfolio
0.23%
Previous 0.21%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $56,524 - $68,768
-345 Reduced 15.97%
1,815 $358,000
Q2 2024

Aug 02, 2024

SELL
$154.79 - $180.76 $61,916 - $72,304
-400 Reduced 15.63%
2,160 $370,000
Q1 2024

Apr 29, 2024

BUY
$159.82 - $182.1 $15,982 - $18,210
100 Added 4.07%
2,560 $466,000
Q4 2023

Feb 05, 2024

SELL
$137.6 - $154.97 $7,155 - $8,058
-52 Reduced 2.07%
2,460 $381,000
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $17,901 - $20,723
-134 Reduced 5.06%
2,512 $374,000
Q2 2023

Jul 20, 2023

SELL
$132.51 - $164.9 $42,800 - $53,262
-323 Reduced 10.88%
2,646 $356,000
Q1 2023

May 01, 2023

BUY
$144.61 - $166.54 $65,363 - $75,276
452 Added 17.96%
2,969 $473,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $51,536 - $59,109
384 Added 18.0%
2,517 $338,000
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $72,663 - $92,378
528 Added 32.9%
2,133 $327,000
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $211,827 - $262,818
1,605 New
1,605 $260,000
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $135,036 - $148,658
-1,320 Closed
0 $0
Q4 2020

Jan 28, 2021

BUY
$80.49 - $108.67 $106,246 - $143,444
1,320 New
1,320 $141,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Birchcreek Wealth Management, LLC Portfolio

Follow Birchcreek Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchcreek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Birchcreek Wealth Management, LLC with notifications on news.